Effect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysis
Open accessThe DOI matches its Crossref record; 78 of the 82 references it cites were found in a registry or an index.
Abstract
Purpose Pharmacotherapy is an effective treatment for anxiety disorders, but its effects on quality of life (QOL) have not been examined systematically. Our objective was to conduct an effect size analysis of pharmacological interventions on QOL outcomes in patients with DSM-IV anxiety disorders. Methods Manual and electronic searches using PubMed, PsycINFO, and the Cochrane Library were conducted for records from the first available date through May 1, 2013 for trials of pharmacological interventions in patients with anxiety disorders, which had measures of QOL before and after treatment. Of 1,865 entries, 93 studies were identified as potentially relevant and 32 met inclusion criteria, of which results were examined from 22 studies reporting 27 distinct pharmacological trials, representing data from 4,344 anxiety disorder patients. Data were extracted independently by multiple observers to estimate within-group and placebo-controlled random effects of the treatment changes on QOL. We hypothesized that pharmacotherapy improves QOL, which is associated with improvement in anxiety symptoms. Results Pharmacological interventions effectively improved QOL from before to after treatment (Hedges' g = 0.59), although the controlled effect size is smaller among those trials with placebo interventions (Hedges' g = 0.32). These effect sizes were robust, increased with publication year, and increased with reductions in anxiety symptoms. Conclusions Pharmacological therapy is effective f…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBT and pharmacotherapy both yield small to moderate positive effects on QOL outcomes [8, 65].”
From Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research (2021) · cites this paper as [65]
In the citing paper
“there is good evidence that treatment of anxiety and related disorders improves these domains 128”
From The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management (2021) · cites this paper as [128]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · cited 2×
“62, which is considered a good strength of agreement [14].”
BackgroundMethodEuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052 · cited 1×
“Anxiety disorders are prevalent psychiatric disorders [1] that are associated with high personal and economic costs [2] and low quality of life (QOL) [3–6] that may be even greater than the influence of chronic medical disorders [7, 8].”
Background
Research works printed but not linked: 1
- Borenstein, M., Hedges, L. V., Higgins, J., & Rothstein, H. (2005). Comprehensive meta-analysis, version 2. Englewood, NJ: Biostat Inc.
Cited by
Newby, J. M., McKinnon, A., Kuyken, W., Gilbody, S., & Dalgleish, T. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.06.002 · Cited by 545
Short‐term neuropsychiatric outcomes and quality of life in COVID‐19 survivors
Méndez, R., Balanzá‐Martínez, V., Luperdi, S. C., Estrada, I., Latorre, A., González‐Jiménez, P., Feced, L., Bouzas, L., Yépez, K., Ferrando, A., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13262 · Cited by 241
Effect of treatments for depression on quality of life: a meta-analysis
Hofmann, S. G., Curtiss, J., Carpenter, J. K., & Kind, S. (2017) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2017.1304445 · Cited by 189
Self-citationZhou, Y., Cao, Z., Yang, M., Xi, X., Guo, Y., Fang, M., Cheng, L., & Du, Y. (2017) · Scientific Reports · doi:10.1038/srep40511 · Cited by 152
Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research
Wilmer, M. T., Anderson, K., & Reynolds, M. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01290-4 · Cited by 150
Metadata
- Authors
- Hofmann, S. G., Wu, J. Q., Boettcher, H., & Sturm, J.
- Affiliations
- Boston University (US)
- Corresponding author
- Hofmann, Stefan G.
- Venue
- Quality of Life Research
- Published
- 2013-11-16
- Volume
- 23
- Issue
- 4
- Pages
- 1141-1153
- ISSN
- 0962-9343 (ISSN-L)
- 1573-2649
- PMC
- PMC3966969
- OpenAlex
- W1974133494
- Cited by
- 24
- References
- 82
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2021: 4 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 2
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Quality of Life Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Center for Complementary and Integrative Health (R01AT007257)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- anxiety disorders, pharmacotherapy, quality of life, antidepressants, anxiolytics, symptom relief, treatment effect size
- MeSH terms
- Anxiety Disorders, Humans, Psychopharmacology, Quality of Life, Anti-Anxiety Agents, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysis. https://app.cochat.ai/papers/10.1007/s11136-013-0573-8
- The paper
- Hofmann, S. G., Wu, J. Q., Boettcher, H., & Sturm, J. (2014). Effect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysis. Quality of Life Research. https://doi.org/10.1007/s11136-013-0573-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.